Autocrine	O
angiogenic	O
vascular	B-Multi-tissue_structure
prosthesis	O
with	O
bone	B-Multi-tissue_structure
marrow	I-Multi-tissue_structure
transplantation	O
.	O

Synthetic	O
vascular	B-Multi-tissue_structure
prostheses	O
are	O
foreign	O
bodies	O
,	O
so	O
that	O
blood	B-Organism_substance
coagulation	O
can	O
occur	O
on	O
their	O
luminal	B-Multi-tissue_structure
surfaces	I-Multi-tissue_structure
,	O
causing	O
graft	B-Multi-tissue_structure
occlusion	O
very	O
frequently	O
in	O
prostheses	O
of	O
small	O
diameter	O
.	O

A	O
vascular	B-Multi-tissue_structure
prosthesis	O
needs	O
angiogenesis	O
for	O
endothelialization	O
of	O
the	O
luminal	B-Multi-tissue_structure
surface	I-Multi-tissue_structure
,	O
as	O
endothelial	B-Cell
cells	I-Cell
have	O
natural	O
and	O
permanent	O
antithrombogenic	O
properties	O
.	O

To	O
induce	O
capillary	B-Tissue
growth	O
into	O
the	O
graft	B-Multi-tissue_structure
,	O
we	O
developed	O
a	O
method	O
of	O
transplanting	O
bone	B-Cell
marrow	I-Cell
cells	I-Cell
,	O
which	O
are	O
primitive	O
,	O
strong	O
enough	O
to	O
survive	O
,	O
and	O
create	O
blood	B-Cell
cells	I-Cell
,	O
resulting	O
in	O
the	O
inducement	O
of	O
capillary	B-Tissue
growth	O
.	O

In	O
an	O
animal	O
experiment	O
,	O
marrow	B-Cell
cells	I-Cell
were	O
infiltrated	O
into	O
the	O
walls	O
of	O
long	O
-	O
fibril	O
expanded	O
polytetrafluoroethylene	O
(	O
ePTFE	O
)	O
vascular	B-Multi-tissue_structure
grafts	I-Multi-tissue_structure
.	O

The	O
grafts	B-Multi-tissue_structure
were	O
implanted	O
in	O
the	O
abdominal	B-Multi-tissue_structure
aortic	I-Multi-tissue_structure
position	O
of	O
24	O
dogs	O
autologously	O
.	O

Marrow	B-Cell
cells	I-Cell
survived	O
and	O
continued	O
exogenous	O
hemopoiesis	O
for	O
up	O
to	O
six	O
months	O
and	O
were	O
immunohistochemically	O
reactive	O
to	O
basic	O
fibroblast	O
growth	O
factor	O
(	O
bFGF	O
)	O
.	O

All	O
the	O
grafts	B-Multi-tissue_structure
older	O
than	O
three	O
weeks	O
had	O
complete	O
endothelialization	O
and	O
maintained	O
their	O
patency	O
.	O

Twenty	O
grafts	B-Multi-tissue_structure
without	O
bone	B-Multi-tissue_structure
marrow	I-Multi-tissue_structure
were	O
implanted	O
as	O
controls	O
.	O

Endothelialization	O
was	O
present	O
at	O
anastomotic	B-Tissue
sites	I-Tissue
,	O
but	O
other	O
areas	O
were	O
covered	O
with	O
fresh	O
thrombi	B-Pathological_formation
.	O

Four	O
out	O
of	O
seven	O
control	O
grafts	B-Multi-tissue_structure
were	O
patent	O
with	O
endothelial	B-Cell
cell	I-Cell
lining	O
at	O
six	O
months	O
,	O
but	O
three	O
were	O
occluded	O
and	O
one	O
of	O
the	O
four	O
grafts	B-Multi-tissue_structure
was	O
still	O
covered	O
with	O
a	O
thrombus	B-Pathological_formation
layer	I-Pathological_formation
.	O

Bone	B-Multi-tissue_structure
marrow	I-Multi-tissue_structure
with	O
its	O
unique	O
native	O
properties	O
produced	O
autocrine	O
angiogenicity	O
in	O
the	O
graft	B-Multi-tissue_structure
.	O

